Author Details

Lichinitser, M. R

Issue	Section	Title	File
No 2S (2008)	Articles	Effektivnost' i bezopasnost' lapatiniba v kombinatsii s kapetsitabinom pri lechenii bol'nykh HER-2 pozitivnym metastaticheskim rakom molochnoy zhelezy
No 18 (2012)	Articles	Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
No 17 (2013)	Articles	Refnot® – novyy immunomodulyator dlya lecheniya onkologicheskikh bol'nykh
No 8 (2015)	Articles	Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
No 18 (2015)	Articles	Kadsila (trastuzumab emtanzin, T-DM1): pervyy kon\"yugat antitela i khimiopreparata v lechenii HER2-polozhitel'nogo raka molochnoy zhelezy
No 18 (2015)	Articles	15-letniy opyt ispol'zovaniya Gertseptina pri HER2-pozitivnom rake molochnoy zhelezy
No 18 (2015)	Articles	Klinicheskiy sluchay uspeshnogo lecheniya HER-pozitivnogo disseminirovannogo raka zheludka s polnym i prodolzhitel'nym effektom
No 17 (2016)	Articles	RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"